Life Sciences

Enterprise MLOps for Drug Discovery

How a custom MLOps platform enabled a pharma company to train, deploy, and monitor hundreds of ML models- without rebuilding their existing infrastructure.

Life Sciences

Enterprise MLOps for Drug Discovery

How a custom MLOps platform enabled a pharma company to train, deploy, and monitor hundreds of ML models- without rebuilding their existing infrastructure.

Drug Discovery Optimization & MLOps Platform for Global Top 20 Pharmaceutical Firm

Published: April 10, 2024

Learn how Reveal's MLOps platform helped a leading pharmaceutical company train, deploy, run, manage, and monitor hundreds of machine learning (ML) models to optimize drug discovery efforts.

Implementing Multiple ML Models at Scale with Existing Infrastructure

Our client wanted to leverage ML models to aid in drug discovery. However, ML models need a large number of labeled datasets for training. Additionally, deploying these ML models on the client’s available infrastructure represented changes in scalability & bandwidth.

Reveal’s MLOps Solution

After collaborating with our client to review these challenges in detail, Reveal developed a customized MLOps platform for their needs. This platform leveraged off-the-shelf components such as SageMaker, MLFlow, and Grafana with appropriate tweaks to support our client’s unique circumstances. It was able to train, deploy, run, manage, and monitor hundreds of ML models at scale. The platform was built with APIs that had appropriate access controls to support the needs of different teams throughout the organization, both technical & non-technical.

Positive Client Results

Once the MLOps platform was built and implemented, the client observed the following improvements:

  1. Access control became simple to implement, thereby helping improve efficiency across teams
  2. Training, deploying, running, managing and monitoring hundreds of ML models became feasible within the client’s infrastructure at a nominal investment
  3. The client was able to focus on their most important priority – drug discovery – with much faster turnaround cycles

CASE STUDY

Dynamic Biomarker Modeling with AI

Using time-series clinical data and Neural ODE models to predict patient outcomes, helping life sciences teams improve biomarker discovery and clinical decisions.

CASE STUDY

AI Scheduling for Home Care

An AI scheduling platform that slashed manual work by 90%, uncovered millions in savings, and boosted EBITDA for a fast-growing home care provider.

CASE STUDY

Automated Preventive Care Pathways

Automating preventive care pathways with AWS- improving patient engagement, risk stratification, and operational efficiency across a leading diagnostic network.

Unify Your Data. Accelerate Your Research.

AI for Every Stage of Discovery.